Cargando…

Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis

Studies have demonstrated that angiotensin II has been involved in immune and inflammatory responses which might contribute to the pathogenesis of immune-mediated diseases. Recent evidence suggests that oxidative stress may play a role in myocarditis. Here, we investigated whether olmesartan, an AT(...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukumaran, Vijayakumar, Watanabe, Kenichi, Veeraveedu, Punniyakoti T., Gurusamy, Narasimman, Ma, Meilei, Thandavarayan, Rajarajan A., Lakshmanan, Arun Prasath, Yamaguchi, Ken'ichi, Suzuki, Kenji, Kodama, Makoto
Formato: Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048845/
https://www.ncbi.nlm.nih.gov/pubmed/21383952
_version_ 1782199193020923904
author Sukumaran, Vijayakumar
Watanabe, Kenichi
Veeraveedu, Punniyakoti T.
Gurusamy, Narasimman
Ma, Meilei
Thandavarayan, Rajarajan A.
Lakshmanan, Arun Prasath
Yamaguchi, Ken'ichi
Suzuki, Kenji
Kodama, Makoto
author_facet Sukumaran, Vijayakumar
Watanabe, Kenichi
Veeraveedu, Punniyakoti T.
Gurusamy, Narasimman
Ma, Meilei
Thandavarayan, Rajarajan A.
Lakshmanan, Arun Prasath
Yamaguchi, Ken'ichi
Suzuki, Kenji
Kodama, Makoto
author_sort Sukumaran, Vijayakumar
collection PubMed
description Studies have demonstrated that angiotensin II has been involved in immune and inflammatory responses which might contribute to the pathogenesis of immune-mediated diseases. Recent evidence suggests that oxidative stress may play a role in myocarditis. Here, we investigated whether olmesartan, an AT(1)R antagonist protects against experimental autoimmune myocarditis (EAM) by suppression of oxidative stress, endoplasmic reticulum (ER) stress and inflammatory cytokines. EAM was induced in Lewis rats by immunization with porcine cardiac myosin, were divided into two groups and treated with either olmesartan (10 mg/kg/day) or vehicle for a period of 21 days. Myocardial functional parameters measured by hemodynamic and echocardiographic analyses were significantly improved by the treatment with olmesartan compared with those of vehicle-treated rats. Treatment with olmesartan attenuated the myocardial mRNA expressions of proinflammatory cytokines, [Interleukin (IL)-1β, monocyte chemoattractant protein-1, tumor necrosis factor-α and interferon-γ)] and the protein expression of tumor necrosis factor-α compared with that of vehicle-treated rats. Myocardial protein expressions of AT(1)R, NADPH oxidase subunits (p47phox, p67phox, gp91phox) and the expression of markers of oxidative stress (3-nitrotyrosine and 4-hydroxy-2-nonenal), and the cardiac apoptosis were also significantly decreased by the treatment with olmesartan compared with those of vehicle-treated rats. Furthermore, olmesartan treatment down-regulated the myocardial expressions of glucose regulated protein-78, growth arrest and DNA damage-inducible gene, caspase-12, phospho-p38 mitogen-activated protein kinase (MAPK) and phospho-JNK. These findings suggest that olmesartan protects against EAM in rats, at least in part via suppression of oxidative stress, ER stress and inflammatory cytokines.
format Text
id pubmed-3048845
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-30488452011-03-07 Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis Sukumaran, Vijayakumar Watanabe, Kenichi Veeraveedu, Punniyakoti T. Gurusamy, Narasimman Ma, Meilei Thandavarayan, Rajarajan A. Lakshmanan, Arun Prasath Yamaguchi, Ken'ichi Suzuki, Kenji Kodama, Makoto Int J Biol Sci Research Paper Studies have demonstrated that angiotensin II has been involved in immune and inflammatory responses which might contribute to the pathogenesis of immune-mediated diseases. Recent evidence suggests that oxidative stress may play a role in myocarditis. Here, we investigated whether olmesartan, an AT(1)R antagonist protects against experimental autoimmune myocarditis (EAM) by suppression of oxidative stress, endoplasmic reticulum (ER) stress and inflammatory cytokines. EAM was induced in Lewis rats by immunization with porcine cardiac myosin, were divided into two groups and treated with either olmesartan (10 mg/kg/day) or vehicle for a period of 21 days. Myocardial functional parameters measured by hemodynamic and echocardiographic analyses were significantly improved by the treatment with olmesartan compared with those of vehicle-treated rats. Treatment with olmesartan attenuated the myocardial mRNA expressions of proinflammatory cytokines, [Interleukin (IL)-1β, monocyte chemoattractant protein-1, tumor necrosis factor-α and interferon-γ)] and the protein expression of tumor necrosis factor-α compared with that of vehicle-treated rats. Myocardial protein expressions of AT(1)R, NADPH oxidase subunits (p47phox, p67phox, gp91phox) and the expression of markers of oxidative stress (3-nitrotyrosine and 4-hydroxy-2-nonenal), and the cardiac apoptosis were also significantly decreased by the treatment with olmesartan compared with those of vehicle-treated rats. Furthermore, olmesartan treatment down-regulated the myocardial expressions of glucose regulated protein-78, growth arrest and DNA damage-inducible gene, caspase-12, phospho-p38 mitogen-activated protein kinase (MAPK) and phospho-JNK. These findings suggest that olmesartan protects against EAM in rats, at least in part via suppression of oxidative stress, ER stress and inflammatory cytokines. Ivyspring International Publisher 2011-02-11 /pmc/articles/PMC3048845/ /pubmed/21383952 Text en © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.
spellingShingle Research Paper
Sukumaran, Vijayakumar
Watanabe, Kenichi
Veeraveedu, Punniyakoti T.
Gurusamy, Narasimman
Ma, Meilei
Thandavarayan, Rajarajan A.
Lakshmanan, Arun Prasath
Yamaguchi, Ken'ichi
Suzuki, Kenji
Kodama, Makoto
Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis
title Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis
title_full Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis
title_fullStr Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis
title_full_unstemmed Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis
title_short Olmesartan, an AT(1) Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis
title_sort olmesartan, an at(1) antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048845/
https://www.ncbi.nlm.nih.gov/pubmed/21383952
work_keys_str_mv AT sukumaranvijayakumar olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis
AT watanabekenichi olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis
AT veeraveedupunniyakotit olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis
AT gurusamynarasimman olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis
AT mameilei olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis
AT thandavarayanrajarajana olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis
AT lakshmananarunprasath olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis
AT yamaguchikenichi olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis
AT suzukikenji olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis
AT kodamamakoto olmesartananat1antagonistattenuatesoxidativestressendoplasmicreticulumstressandcardiacinflammatorymediatorsinratswithheartfailureinducedbyexperimentalautoimmunemyocarditis